Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System.

Shao S, Gill AA, Zahm SH, Jatoi I, Shriver CD, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):50-57. doi: 10.1158/1055-9965.EPI-17-0439. Epub 2017 Nov 2.

PMID:
29097445
2.

Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.

Benson JR, Jatoi I.

Future Oncol. 2017 Jul;13(16):1365-1369. doi: 10.2217/fon-2017-0089. Epub 2017 Jul 7.

3.

Highlights of the San Antonio Breast Cancer Symposium 2016.

Benson JR, Jatoi I.

Future Oncol. 2017 Jun;13(15):1291-1295. doi: 10.2217/fon-2017-0088. Epub 2017 Jun 26.

4.

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R.

Nat Commun. 2017 Jun 26;8:15908. doi: 10.1038/ncomms15908.

5.

Reconsidering axillary surgery for early breast cancer.

Jatoi I.

Indian J Med Res. 2017 Feb;145(2):155-157. doi: 10.4103/ijmr.IJMR_1837_16. No abstract available.

6.

Breast-Cancer Tumor Size and Screening Effectiveness.

Jatoi I, Anderson WF.

N Engl J Med. 2017 Jan 5;376(1):93. No abstract available.

PMID:
28060474
7.

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?

Benson JR, Jatoi I, Toi M.

Lancet Oncol. 2016 Oct;17(10):e442-e451. doi: 10.1016/S1470-2045(16)30367-9. Review.

PMID:
27733270
8.

De-escalation of axillary surgery in early breast cancer.

Jatoi I, Benson JR, Toi M.

Lancet Oncol. 2016 Oct;17(10):e430-e441. doi: 10.1016/S1470-2045(16)30311-4. Review.

PMID:
27733269
9.

Management of women with a hereditary predisposition for breast cancer.

Jatoi I, Benson JR.

Future Oncol. 2016 Oct;12(19):2277-88. doi: 10.2217/fon-2016-0186. Epub 2016 Jul 7. Review.

PMID:
27384952
10.

Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing Trend.

Jatoi I.

Indian J Surg Oncol. 2015 Dec;6(4):387-9. doi: 10.1007/s13193-015-0450-8. Epub 2015 Aug 1.

11.

Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Mullooly M, Pfeiffer RM, Nyante SJ, Heckman-Stoddard BM, Perloff M, Jatoi I, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Berrington de Gonzalez A, Sherman ME, Gierach GL.

J Clin Oncol. 2016 Jun 20;34(18):2093-7. doi: 10.1200/JCO.2015.64.4492. Epub 2016 Mar 28. No abstract available.

12.

Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.

Brown D, Shao S, Jatoi I, Shriver CD, Zhu K.

Cancer Epidemiol. 2016 Jun;42:24-31. doi: 10.1016/j.canep.2016.02.011. Epub 2016 Mar 18.

PMID:
26999400
13.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.

Benson JR, Jatoi I.

Future Oncol. 2016 Apr;12(7):893-6. doi: 10.2217/fon-2016-0043. Epub 2016 Feb 15. Erratum in: Future Oncol. 2016 May;12(9):1206.

14.

Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.

Benson JR, Jatoi I.

Future Oncol. 2016 Apr;12(7):897-900. doi: 10.2217/fon-2016-0044. Epub 2016 Feb 15.

15.

Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?

Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L, Jatoi I, Brunt AM; MIAMI (Multiple Ipsilateral breast conserving surgery versus mastectomy) Trial Management Group.

Breast. 2016 Apr;26:149-50. doi: 10.1016/j.breast.2015.12.011. Epub 2016 Feb 3. No abstract available.

PMID:
26851965
16.

Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.

Jatoi I, Bandos H, Jeong JH, Anderson WF, Romond EH, Mamounas EP, Wolmark N.

J Natl Cancer Inst. 2015 Oct 30;108(1). pii: djv304. doi: 10.1093/jnci/djv304. Print 2016 Jan.

17.

Breast Cancer Screening in Elderly Women: Primum Non Nocere.

Jatoi I, Miller AB.

JAMA Surg. 2015 Dec;150(12):1107-8. doi: 10.1001/jamasurg.2015.2663. Review. No abstract available.

PMID:
26465234
18.

Breast-Cancer Screening--Viewpoint of the IARC Working Group.

Jatoi I.

N Engl J Med. 2015 Oct 8;373(15):1478-9. doi: 10.1056/NEJMc1508733#SA2. No abstract available.

PMID:
26444744
19.

Breast cancer screening: past, present and future.

Jatoi I.

Future Oncol. 2015 Sep 4. [Epub ahead of print] No abstract available.

PMID:
26338534
20.

Spatiotemporal control of estrogen-responsive transcription in ERĪ±-positive breast cancer cells.

Hsu PY, Hsu HK, Hsiao TH, Ye Z, Wang E, Profit AL, Jatoi I, Chen Y, Kirma NB, Jin VX, Sharp ZD, Huang TH.

Oncogene. 2016 May 5;35(18):2379-89. doi: 10.1038/onc.2015.298. Epub 2015 Aug 24.

Supplemental Content

Loading ...
Support Center